A Maternal Vaccine Study for Group B Strep
You may be eligible* to participate if you:
- are a healthy 18-40 years old female between ≥24 0/7 to ≤35 6/7 weeks gestation on the day of planned vaccination
- are having an uncomplicated, singleton pregnancy (one fetus), at no increased risk for complications, and show no significant fetal abnormalities observed on ultrasound performed at any time prior to study entry and/or at the screening visit.
*additional criteria apply
Speaking in general, vaccines are a part of a healthy pregnancy. When you get vaccinated during pregnancy, you are not only protecting yourself against dangerous, potentially deadly diseases, you are also protecting your baby.
Screening for GBS and intrapartum antibiotic prophylaxis in pregnant women has decreased the rate of GBS in newborns less than 1 week old, but these measures have not had any impact on reducing disease on women and infants older than 1 week.
The investigational vaccine in this study is designed to target the 6 types of GBS that cause the majority of infections in infants. The study vaccine was previously evaluated in nonpregnant women to confirm that is was safe, tolerable, and if it generated an immune response against GBS. The study is now being evaluated in healthy pregnany women.
When a pregnant person gets vaccinated, their body creates protective antibodies (immunity against diseases) and passes some of these antibodies to their baby that will last until their little one is ready to start getting their own vaccines.
For more information or to get started, please complete the confidential inquiry below:
According to the March of Dimes website: